Papers

2

Total Citations

97

H-Index

2

About

Dr. Paul Lee is a pioneering surgeon whose work bridges the frontiers of urologic oncology and advanced thoracic surgery. His research is defined by two distinct yet equally impactful contributions. In urology, Dr. Lee developed a landmark clinical tool using neutrophil and lymphocyte counts to stratify low-risk prostate cancer patients, a non-invasive method that has garnered 50 citations and offers a powerful new avenue for personalized treatment decisions. Simultaneously, he has revolutionized the surgical management of severe tracheobronchomalacia. As the lead author of the first-ever series of minimally invasive, robot-assisted tracheobronchoplasty with mesh, his 2018 study (47 citations) demonstrated that a complex, debilitating airway disease can be treated with significantly reduced morbidity compared to traditional open surgery. Dr. Lee’s ability to apply cutting-edge robotic technology to solve long-standing surgical challenges, while also developing simple, effective biomarkers, marks him as a versatile and visionary clinician-scientist whose work directly improves patient outcomes across multiple specialties.

Research Focus

Key Achievements

2
H-Index
2
Papers
97
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer
50 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Rutgers, The State University of New Jersey, Long Island Jewish Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago